Newsroom archive

23 . 04 .2013
Press release
Nuvo Research announces European Launch of PLIAGLIS® by Galderma
READ MORE
12 . 12 .2012
Press release
Galderma, World's leading company focused exclusively on Dermatology, acquires Spirig
READ MORE
24 . 09 .2012
Press release
Galderma and NovaBay Enroll First Patients in Phase 2b Clinical Study of NVC-422 for Impetigo
READ MORE
19 . 04 .2012
Press release
Q-Med discontinues the Breast Indication for Macrolane
READ MORE
20 . 03 .2012
Press release
Galderma announces Completion of Phase 3 Trials of Investigational Drug targeting Facial Erythema of Rosacea
READ MORE
12 . 03 .2012
Press release
Ipsen and Galderma increase their collaboration for Dysport® in new territories
READ MORE
06 . 03 .2012
Press release
Galderma receives FDA Approval for new convenient Pump Dispenser of Differin Gel, 0.3% for treatment of Acne Vulgaris
READ MORE
17 . 01 .2012
Press release
Galderma Announces Availability of New Metrogel 1% Pump Dispenser for the Treatment of Papulopustular Rosacea
READ MORE
20 . 10 .2011
Press release
Galderma announces positive US pivotal interim 6-month results for EMERVEL Classic Lidocaine compared to JUVEDERM Ultra
READ MORE
20 . 10 .2011
Press release
Galderma announces positive Phase 2B Results for Investigational Compound targeting Redness of Rosacea
READ MORE